Spiro Medical Funding: $67M Raised, Series A (2026)
Spiro Medical is a Biotech company based in Irvine. It has raised $67M in total funding. Latest round: Series A.
Spiro Medical funding overview
Spiro Medical is a Biotech company based in Irvine. Spiro Medical has raised $67M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2026. The round record for Spiro Medical runs through 2026; nothing later has been disclosed. Investors on record include Andera Partners, Omega Funds, Sherpa Healthcare Partners, HSG, Supernova Invest, Northern Light Venture Capital and 1 others. 7 distinct backers are named across the disclosed rounds.
Spiro Medical has raised $67M in total disclosed funding across the rounds on record.
Who has invested in Spiro Medical?
Andera Partners, Omega Funds, Sherpa Healthcare Partners, HSG, Supernova Invest, Northern Light Venture Capital are named among the investors backing Spiro Medical.
What was the latest Spiro Medical funding round?
The most recent disclosed round is a Series A, announced in January 2026.
Where is Spiro Medical based?
Spiro Medical is based in Irvine.
What sector does Spiro Medical operate in?
Spiro Medical is tracked under Biotech from Irvine, with $67M in disclosed funding.
When did Spiro Medical last raise?
The last disclosed Spiro Medical round closed in January 2026 at Series A.
Totals shown for Spiro Medical aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in Irvine and the investors behind them below.
